Nonpsychoactive Cannabidiol Prevents Prion Accumulation and Protects Neurons against Prion Toxicity
Open Access
- 5 September 2007
- journal article
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 27 (36), 9537-9544
- https://doi.org/10.1523/jneurosci.1942-07.2007
Abstract
Prion diseases are transmissible neurodegenerative disorders characterized by the accumulation in the CNS of the protease-resistant prion protein (PrPres), a structurally misfolded isoform of its physiological counterpart PrPsen. Both neuropathogenesis and prion infectivity are related to PrPres formation. Here, we report that the nonpsychoactive cannabis constituent cannabidiol (CBD) inhibited PrPres accumulation in both mouse and sheep scrapie-infected cells, whereas other structurally related cannabinoid analogs were either weak inhibitors or noninhibitory. Moreover, after intraperitoneal infection with murine scrapie, peripheral injection of CBD limited cerebral accumulation of PrPres and significantly increased the survival time of infected mice. Mechanistically, CBD did not appear to inhibit PrPres accumulation via direct interactions with PrP, destabilization of PrPres aggregates, or alteration of the expression level or subcellular localization of PrPsen. However, CBD did inhibit the neurotoxic effects of PrPres and affected PrPres-induced microglial cell migration in a concentration-dependent manner. Our results suggest that CBD may protect neurons against the multiple molecular and cellular factors involved in the different steps of the neurodegenerative process, which takes place during prion infection. When combined with its ability to target the brain and its lack of toxic side effects, CBD may represent a promising new anti-prion drug.This publication has 33 references indexed in Scilit:
- Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: Relevance to Parkinson's diseaseNeurobiology of Disease, 2005
- Specific inhibition of pathological prion protein accumulation by small interfering RNAsJournal of Cell Science, 2003
- Prion Diseases: What Is the Neurotoxic Molecule?Neurobiology of Disease, 2001
- Efficient Conversion of Normal Prion Protein (PrP) by Abnormal Hamster PrP Is Determined by Homology at Amino Acid Residue 155Journal of Virology, 2001
- Successful Transmission of Three Mouse-Adapted Scrapie Strains to Murine Neuroblastoma Cell Lines Overexpressing Wild-Type Mouse Prion ProteinJournal of Virology, 2000
- PrP and β-Amyloid Fragments Activate Different Neurotoxic Mechanisms in Cultured Mouse CellsEuropean Journal of Neuroscience, 1997
- Cell-free formation of protease-resistant prion proteinNature, 1994
- Degeneration of skeletal muscle, peripheral nerves, and the central nervous system in transgenic mice overexpressing wild-type prion proteinsCell, 1994
- Cytoprotective effect of NMDA receptor antagonists on prion protein (PrionSc)-induced toxicity in rat cortical cell culturesEuropean Journal of Pharmacology: Molecular Pharmacology, 1993
- Potent Inhibition of Scrapie‐Associated PrP Accumulation by Congo RedJournal of Neurochemistry, 1992